# Guardant Health to acquire Bellwether Bio

Guardant Health agreed to acquire Bellwether Bio, a private company focused on epigenomic research for early cancer detection, for an undisclosed sum.

- Type: Acquisition
- Announced: 2019-03-27
- Where: Redwood City, California, United States
- Status: announced
- Products: early cancer detection tests
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Guardant Health](https://endata.com/companies/38275.md) (acquirer)
- [Bellwether Bio](https://endata.com/companies/38276.md) (target)

## Sources

- [mddionline.com](https://www.mddionline.com/ivd/guardant-tests-out-m-a-waters-with-bellwether-bio), 2019-03-27: "We are excited to welcome the Bellwether team and believe they will enhance our product pipeline as we seek to expand precision oncology to earlier stages of disease."
- [comotion.uw.edu](https://comotion.uw.edu/blog/uw-spinout-bellwether-bio-acquired-by-guardant-health/), 2019-04-19: "precision oncology company Guardant Health (NASDAQ: GH) announced that it will be acquiring Bellwether Bio, a University of Washington spinout that develops next generation cancer diagnostics using cell-free DNA."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.